Biotech

All Articles

Turnstone lays off 60%, shakes up C-suite to extend money

.Turnstone Biologics is minimizing its head count by 60% and agitating its own C-suite so as to main...

Gilead loses hope on $15M MASH bet after reviewing preclinical data

.In a year that has found an authorization as well as a plethora of readouts for metabolic dysfuncti...

Texas biotech centers cancer deal, pins really hopes on being overweight

.Alaunos Rehabs is axing a contract along with Precigen, giving up licensing civil rights to a tailo...

Capricor portions more records for DMD treatment after initiating BLA

.Capricor Rehabs is actually taking a success tour for their phase 2 Duchenne muscular dystrophy (DM...

FDA places Kezar lupus trial in grip following 4 person deaths

.The FDA has actually placed Kezar Lifestyle Sciences' lupus trial on hold after the biotech flagged...

Phase 3 Scholar Stone test hits SMA target, sending out stock up 200%

.A period 3 trial of Academic Rock's back muscular degeneration (SMA) prospect has attacked its prim...

CAMP 4 is actually most up-to-date to eye IPO, while Upstream define $182M plan

.RNA biotech CAMP4 Rehabs has actually defined plans for a $67 thousand IPO, with inflammation-focus...

Galecto acquires leukemia medication, goes down bone tissue cancer cells asset in pivot

.A year after the failure of an idiopathic pulmonary fibrosis applicant sent Galecto on a seek salva...

Judo throws down $100M to knock out renal disease

.Taking the mat is actually Judo Biography, an ambitious biotech equipped along with $one hundred mi...

AstraZeneca pays out CSPC $100M for preclinical cardiovascular disease medication

.AstraZeneca has settled CSPC Drug Group $100 million for a preclinical heart attack drug. The offer...